Synapse - Hematologic Malignancies, Division of

Search Within

Hematologic Malignancies, Division of

Results (13365)

Burden of idiopathic multicentric Castleman disease (iMCD) in the US: A population-level real world analysis using a health-claims dataset

Meeting Abstract

Noy, A.; Ohgami, R.; Munshi, N. C.; Siddiqi, I.; Dacus, K. C.; Saltis, A. W.; Shupo, F.; Princic, N.; Evans, K.; Mukherjee, S.
Blood (2024)

Fulltext@MSK | Save

Daratumumab with dose-adjusted EPOCH is feasible in newly diagnosed plasmablastic lymphoma: AIDS Malignancy Consortium 105

Meeting Abstract

Noy, A.; Barta, S. K.; Kwon, D.; Baiocchi, R.; Ramos, J. C.; Rubinstein, P.; Chadburn, A.; Ambinder, R. F.
Blood (2024)

Fulltext@MSK | Save

Fixed-duration glofitamab monotherapy continues to demonstrate durable responses in patients with relapsed or refractory large B-cell lymphoma: 3-year follow-up from a pivotal phase II study

Meeting Abstract

Dickinson, M. J.; Carlo-Stella, C.; Morschhauser, F.; Bachy, E.; Cartron, G.; Corradini, P.; Bartlett, N. L.; Iacoboni, G.; Khan, C.; Hertzberg, M. S.; more...
Blood (2024)

Fulltext@MSK | Save

CD38 overexpressed monocytes play a critical role in the fibrogenesis in myeloproliferative neoplasms and can be used as a therapeutic target to ameliorate fibrosis

Meeting Abstract

Yan, Y.; Liu, J.; Yang, L.; Huang, G.; Zhu, X.; Rampal, R.; Xiao, Z.; Li, B.
Blood (2024)

Fulltext@MSK | Save

Barriers to immune effector cell therapy: Rapid disease progression, concern for toxicity, and lack of appropriate trials drive non-receipt after referral at a large academic center

Meeting Abstract

Valtis, Y. K.; Chin, K. K.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; Brooklyn, C.; Goldstein, T.; more...
Blood (2024)

Fulltext@MSK | Save

Prediction of post-transplant relapse of the myelodysplastic syndromes via evaluation of stem cells

Meeting Abstract

Kroger, B.; Tamari, R.; Gurnari, C.; Thiebaud, J. A.; Velarde, A. M.; Madanat, Y. F.; Collins, R. H.; Jackson, C.; Gatell, V. I.; Visconte, V.; more...
Blood (2024)

Fulltext@MSK | Save

HMGA1 chromatin regulators disrupt 3D genome architecture and chromatin looping to repress MHC II genes and drive immune evasion during MPN progression

Meeting Abstract

Resar, L.; Kim, J.; Supreme, A. A.; Woo, H.; West, B.; Antopia, M. C.; Thompson, Z.; Reddy, K.; Kim, J. H.; Cope, L.; more...
Blood (2024)

Fulltext@MSK | Save

Phase II study of longitudinal geriatric assessment with risk-adapted interventions to reduce non-relapse mortality in allogeneic hematopoietic cell transplantation for older patients with advanced myeloid malignancies

Meeting Abstract

Lin, R. J.; Kim, S. J.; Brown, S.; Hanley, D. M.; Engstler, D. E.; Politikos, I.; Gyurkocza, B.; Tamari, R.; Papadopoulos, E. B.; Saldia, A.; more...
Blood (2024)

Fulltext@MSK | Save

Whole genome sequencing reveals lower APOBEC-mutational activity in multiple myeloma patients with African ancestry compared with those having European ancestry

Meeting Abstract

Maclachlan, K. H.; Papadimitriou, M.; Blaney, P.; Shekarkhand, T.; Chu, T. R.; Poos, A. M.; Brown, E.; Hoering, A.; Diamond, B.; Ziccheddu, B.; more...
Blood (2024)

Fulltext@MSK | Save

The Composite Health Risk Assessment Model (CHARM) predicts risks of toxicities, functional and cognitive decline among survivors of allogeneic hematopoietic cell transplantation (allo-HCT): A prospective BMT-CTN study 1704

Meeting Abstract

Sorror, M.; Saber, W.; Logan, B. R.; Geller, N.; Bellach, A.; Kou, J.; Wood, W. A.; McCarty, J. M.; Knight, T. G.; Runaas, L.; more...
Blood (2024)

Fulltext@MSK | Save